| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |